DPP4 and COVID-19: In conclusion, from this review, the immense potential of DPPIV has become clear not only as a co-receptor of SARS-CoV-2 but also as a main mediator in metabolic–inflammatory cascades leading to the aggravation of post-COVID-19 fatigue and cerebrovascular complications.